USD
$0.00
(0.00%
)At Close (As of Dec 11, 2025)
$783.50M
Market Cap
-
P/E Ratio
-2.06
EPS
$50.40
52 Week High
$16.54
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | -$58K |
| Total Revenue | $0 |
| Cost Of Revenue | $58K |
| Costof Goods And Services Sold | $58K |
| Operating Income | -$59M |
| Selling General And Administrative | $29M |
| Research And Development | $30M |
| Operating Expenses | $59M |
| Investment Income Net | - |
| Net Interest Income | $8.6M |
| Interest Income | $8.6M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $58K |
| Income Before Tax | -$50M |
| Income Tax Expense | $1K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$50M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$50M |
| Ebitda | -$50M |
| Net Income | -$50M |
| Field | Value (USD) |
|---|---|
| Total Assets | $215M |
| Total Current Assets | $212M |
| Cash And Cash Equivalents At Carrying Value | $20M |
| Cash And Short Term Investments | $20M |
| Inventory | - |
| Current Net Receivables | - |
| Total Non Current Assets | $3.4M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $189M |
| Other Current Assets | $2.9M |
| Other Non Current Assets | - |
| Total Liabilities | $11M |
| Total Current Liabilities | $10M |
| Current Accounts Payable | $4.3M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $567K |
| Total Non Current Liabilities | $814K |
| Capital Lease Obligations | $1.4M |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $1.4M |
| Other Current Liabilities | $5.6M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $204M |
| Treasury Stock | - |
| Retained Earnings | -$145M |
| Common Stock | $1K |
| Common Stock Shares Outstanding | $21M |
| Field | Value (USD) |
|---|---|
| Gross Profit | -$58K |
| Total Revenue | $0 |
| Cost Of Revenue | $58K |
| Costof Goods And Services Sold | $58K |
| Operating Income | -$59M |
| Selling General And Administrative | $29M |
| Research And Development | $30M |
| Operating Expenses | $59M |
| Investment Income Net | - |
| Net Interest Income | $8.6M |
| Interest Income | $8.6M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $58K |
| Income Before Tax | -$50M |
| Income Tax Expense | $1K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$50M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$50M |
| Ebitda | -$50M |
| Net Income | -$50M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None